Showing results (661-670 of 672) with videos related to

Sort By:
Pageof 68
BMC Neurology|January 12, 2022
Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the NetherlandsFaysal Benali, Lotte J Stolze, Anouk D Rozeman, et al.
Age and Ageing|May 5, 2021
Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD studyLaura C Blomaard, Carolien M J van der Linden, Jessica M van der Bol, et al.
Lancet (London, England)|March 3, 2022
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trialWouter van der Steen, Rob A van de Graaf, Vicky Chalos, et al.
JAMA Neurology|December 31, 2015
Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical TrialPuck S S Fransen, Olvert A Berkhemer, Hester F Lingsma, et al.
The New England Journal of Medicine|December 18, 2014
A randomized trial of intraarterial treatment for acute ischemic strokeOlvert A Berkhemer, Puck S S Fransen, Debbie Beumer, et al.
The New England Journal of Medicine|November 10, 2021
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for StrokeNatalie E LeCouffe, Manon Kappelhof, Kilian M Treurniet, et al.
Stroke|February 9, 2022
Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN RegistryKars C J Compagne, Manon Kappelhof, Wouter H Hinsenveld, et al.
European Stroke Journal|May 3, 2025
National trends in patient characteristics, interventional techniques and outcomes of endovascular treatment for acute ischaemic stroke: Final results of the MR CLEAN Registry (2014-2018)Wouter H Hinsenveld, Josje Brouwer, Sanne J den Hartog, et al.
Lancet (London, England)|April 1, 2023
Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trialSusanne G H Olthuis, F Anne V Pirson, Florentina M E Pinckaers, et al.
JAMA Network Open|June 10, 2025
Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital PatientsFelix Busch, Lena Hoffmann, Lina Xu, et al.
Pageof 68